Polyethylene Glycol (3350) (Mylan Institutional Inc.)


Welcome to the PulseAid listing for the Polyethylene Glycol (3350) drug offered from Mylan Institutional Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional Inc.
NON-PROPRIETARY NAME: polyethylene glycol (3350)
SUBSTANCE NAME: POLYETHYLENE GLYCOL 3500
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2009-11-20
END MARKETING DATE: 0000-00-00


Polyethylene Glycol (3350) HUMAN OTC DRUG Details:

Item DescriptionPolyethylene Glycol (3350) from Mylan Institutional Inc.
LABELER NAME: Mylan Institutional Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 17(g/17g)
START MARKETING DATE: 2009-11-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51079-306_f0437ae6-e4f0-49dc-ad06-301da07c8118
PRODUCT NDC: 51079-306
APPLICATION NUMBER: ANDA078915

Other POLYETHYLENE GLYCOL 3500 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthPolyethylene Glycol (3350)
Mylan Institutional Inc.Polyethylene Glycol (3350)